Immune system

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

Retrieved on: 
Tuesday, March 26, 2024
Research, Head, Clinical Cancer Research, Immunotherapy, Patient, Tumor microenvironment, Durvalumab, Cancer, AI, CCR, AACR, Phenotype, Yonsei University, Immune system, Therapy

SEOUL, South Korea, March 26, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the publication of a new study featuring Lunit SCOPE IO, Lunit's AI-powered analyzer for quantitative immune phenotyping from H&E. The study was recently published in Clinical Cancer Research (CCR), an international journal by the American Association for Cancer Research (AACR).

Key Points: 
  • The study was recently published in Clinical Cancer Research (CCR), an international journal by the American Association for Cancer Research (AACR).
  • This investigation addresses the current lack of exploration into the clinical implications of neoadjuvant immunotherapy in HNSCC patients with resectable tumors, utilizing Lunit SCOPE IO to examine the changes in tumor microenvironment when treated with durvalumab and tremelimumab.
  • "Through this prospective clinical study, we have confirmed the clinical utility of preoperative immunotherapy for treating locally advanced head and neck cancer," said Professor Kim Hye Ryun, head of the research.
  • "In this study, Lunit SCOPE IO provides deeper insights into the tumor microenvironment and immune response, empowering healthcare professionals with invaluable information to make more informed treatment decisions.

MOJO Health Launches Revolutionary EMF Shielding Tranquility Blanket

Retrieved on: 
Monday, March 25, 2024
Immune system, Oxidative stress, Wi-Fi, EMF, Health, Tablet, Tranquillity, Wrist, Love, Cancer, Mobile phone

ATLANTA, March 25, 2024 /PRNewswire-PRWeb/ -- In efforts to further its mission to make holistic healthcare accessible to all and to evolve the cancer healing process to include the best of both conventional and traditional healing methodologies, MOJO Health is excited to announce the launch of its revolutionary EMF Shielding Tranquility Blanket.

Key Points: 
  • ATLANTA, March 25, 2024 /PRNewswire-PRWeb/ -- In efforts to further its mission to make holistic healthcare accessible to all and to evolve the cancer healing process to include the best of both conventional and traditional healing methodologies, MOJO Health is excited to announce the launch of its revolutionary EMF Shielding Tranquility Blanket.
  • It's critical to use every resource, like our Tranquility Blanket, to protect the body from potential negative EMF impacts.
  • "It's critical to use every resource, like our Tranquility Blanket, to protect the body from potential negative EMF impacts.
  • The EMF Shielding Tranquility Blanket is available now on Mojohealth.org for $198.00 for the first 150 blankets sold!

Celebrate National Puppy Day by Giving Your Pups The Best Nutrition With Dr. Marty Pets Nature's Blend

Retrieved on: 
Saturday, March 23, 2024
Salmon, Health, Meat, Pet, Vegetable, Diet, Happiness, Skin, Water, Immune system, Blend, Digestion

LOS ANGELES, March 23, 2024 /PRNewswire/ -- National Puppy Day is March 23, dedicated to honoring the adorable pups that bring boundless happiness into our lives. This special day encourages pet owners to cherish and care for their puppies, ensuring they lead happy and healthy lives. One of the key ways to celebrate is by swapping out highly processed (and harmful) kibble and instead, feeding them a diet of well-balanced, whole food.

Key Points: 
  • Freeze-dried raw food retains the natural goodness of ingredients, offering a biologically balanced diet that supports your pup's overall well-being.
  • Dr. Marty Goldstein, a renowned veterinarian, recommends Dr. Marty Nature's Blend - Essential Wellness for your furry friend.
  • Dr. Marty Nature's Blend - Essential Wellness is a premium freeze-dried raw dog food designed to support your dog's overall well-being.
  • Dr. Marty Nature's Blend can be purchased from the Dr. Marty Pets website for $59.95 or at any retail locations that can be found on our store locator .

ALIVE AND WELL ANNOUNCES NEW LOCATION IN BOULDER

Retrieved on: 
Thursday, March 21, 2024
Well, Ozone, Disease, Patient, Inflammation, Knowledge, Sleep, Dermatology, Immunity, Pediatrics, Intravenous therapy, Immune system, Therapy, FDA, Alive, NAD, Food

AUSTIN, Texas, March 21, 2024 /PRNewswire/ -- Alive and Well, an integrative wellness center, plans to open its newest location in early April in Boulder, Colorado. The new 3,800-square-foot space will be located at the Ideal Broadway Shops.

Key Points: 
  • AUSTIN, Texas, March 21, 2024 /PRNewswire/ -- Alive and Well , an integrative wellness center, plans to open its newest location in early April in Boulder, Colorado.
  • Alive and Well combines traditional practices with cutting-edge therapies by offering a functional medicine clinic, IV therapy, professional-grade supplements, natural beauty products and a compounding pharmacy.
  • * Alive and Well also offers ozone insufflations, which can support the immune system, fight infections, reduce inflammation and increase oxygenated blood flow.
  • To learn more about Alive and Well and its services, visit Instagram , Facebook , TikTok , YouTube and online at www.aliveandwell.health .

Local Heritage and Aging Innovation Come Together at New Aegis Living Community in Ballard

Retrieved on: 
Wednesday, March 20, 2024
Element, Health, Longevity, Aegis, Exercise, Compass, Inflammation, Light, Sleep, Food, Criterion, Meal, Salmon, Market Street, Nature, Wood, Dahlin, Glass, Sculpture, Architecture, Diet, Love, Water, Deadliest Catch, Myalgia, Immune system, Music, Hygge, Burke–Gilman Trail, Nightclub

BELLEVUE, Wash., March 20, 2024 /PRNewswire/ -- Aegis Living, a leader in senior living and memory care, has opened its 37th community in Seattle's Ballard neighborhood, Aegis Living Ballard. Located centrally on Market Street, the new community blends a distinctly Northwest aesthetic with Scandinavian heritage and is a testament to Ballard's rich maritime history and unique neighborhood.

Key Points: 
  • BELLEVUE, Wash., March 20, 2024 /PRNewswire/ -- Aegis Living , a leader in senior living and memory care, has opened its 37th community in Seattle's Ballard neighborhood, Aegis Living Ballard .
  • "Ballard is an eclectic urban neighborhood known for its vibrancy and vitality, which made for the perfect location for our newest community, Aegis Living Ballard," said Aegis Living founder and CEO Dwayne Clark.
  • In addition to its warm, welcoming design, Aegis Living Ballard prioritizes wellness and longevity at the forefront of its care.
  • Aegis Living Ballard is located at 949 NW Market Street, Seattle, WA 98107.

Research case series presents food as medicine as a potential treatment for lupus and other autoimmune diseases

Retrieved on: 
Tuesday, March 19, 2024
Arthralgia, Series, Brain, Xerostomia, Face, Malar rash, Kidney, Lupus, Photosensitivity, Pleurisy, Inflammation, Patient, Raw foodism, Tissue, Research, History, Grit, Hair loss, Food, Seed, MD, Quality of life, Woman, Arthritis, Chronic pain, Skin, Water, Sunlight, Scalp, Immune system, Grain boundary strengthening, Frontiers, RRP, Fatigue, Swelling, Flax, Autoimmune disease, Nut, Medicine, Dietary supplement

ST. LOUIS, March 19, 2024 /PRNewswire-PRWeb/ -- A new research case series published in Frontiers in Nutrition presents food as medicine as a potential treatment for autoimmune diseases, describing three patients with chronic autoimmune disease who showed remarkable improvement after following a predominantly raw dietary pattern high in cruciferous vegetables and omega 3 fatty acids.

Key Points: 
  • ST. LOUIS, March 19, 2024 /PRNewswire-PRWeb/ -- A new research case series published in Frontiers in Nutrition presents food as medicine as a potential treatment for autoimmune diseases, describing three patients with chronic autoimmune disease who showed remarkable improvement after following a predominantly raw dietary pattern high in cruciferous vegetables and omega 3 fatty acids.
  • All three women reported that nearly all their symptoms of both diseases resolved after just four weeks of making the dietary changes.
  • "My hope is that these cases generate greater recognition, making patients and clinicians aware of food as medicine as a treatment option for systemic lupus erythematosus and Sjögren's syndrome.
  • This case series also reflects the immediate need for more research into dietary changes as a potential treatment strategy for autoimmune disease."

International Harrington Prize Awarded to Dr. Arlene Sharpe

Retrieved on: 
Tuesday, March 19, 2024
LDL, Human papillomavirus infection, Patient, DSM-IV codes, Lecture, National Cancer Institute, Harvard University, Creativity, AAP, PD-1, Massachusetts General Hospital, Science, Diabetes, Marfan syndrome, All India Mahila Congress, Immunology, AUC, NIH, Cancer, Nivolumab, Immune system, Biochemistry, Harvard Medical School, Cervical cancer, Research, University, Antibody, ASCI, FDA, Mount Sinai Hospital, Sickle cell disease, University of Pennsylvania, PCSK9, COVID-19, Doctor of Philosophy, Biology, Kidney, Thalassemia, Johns Hopkins University, Society, Division, Leptin, Pharmaceutical industry

CLEVELAND, March 19, 2024 /PRNewswire/ -- The eleventh annual Harrington Prize for Innovation in Medicine has been awarded to Arlene H. Sharpe, MD, PhD, Kolokotrones University Professor and Chair of the Department of Immunology at Harvard Medical School. The award recognizes her breakthrough discoveries in immune regulation, which have established foundational principles in immunology and led to new cancer therapies that act by boosting the immune response to cancer.

Key Points: 
  • CLEVELAND, March 19, 2024 /PRNewswire/ -- The eleventh annual Harrington Prize for Innovation in Medicine has been awarded to Arlene H. Sharpe, MD, PhD, Kolokotrones University Professor and Chair of the Department of Immunology at Harvard Medical School.
  • Her work helped identify key pathways that restrain the activity of T lymphocytes (immune cells) to fight cancer.
  • A committee composed of members of the ASCI Council and the Harrington Discovery Institute Scientific Advisory Board reviewed nominations from leading academic medical centers globally before selecting the 2024 Harrington Prize recipient.
  • 2023: Jean Bennett, MD, PhD, and Albert M. Maguire, MD, for their groundbreaking translational research to restore sight in inherited genetic diseases.

Verb Biotics Announces Data from Preclinical Studies to Support Foundational Gut Microbiome Health from Newly Launched Keystone Postbiotic™

Retrieved on: 
Tuesday, March 19, 2024
Health, Antioxidant, Keystone, Powder, Capsule, Probiotic, Butyric acid, Functional food, Overalls, Cytokine, MOA, Drink, Water, Prebiotic (nutrition), Immune system, Caco-2, Vaccine

BOSTON, March 19, 2024 /PRNewswire/ -- Verb Biotics, a microbiome health ingredient company, today announced preliminary preclinical data from their newly launched Keystone Postbiotic™, a foundational gut microbiome solution to help support and strengthen gut microbiome health.

Key Points: 
  • BOSTON, March 19, 2024 /PRNewswire/ -- Verb Biotics, a microbiome health ingredient company, today announced preliminary preclinical data from their newly launched Keystone Postbiotic™, a foundational gut microbiome solution to help support and strengthen gut microbiome health.
  • Verb Biotics has conducted thorough in-vitro and preliminary human studies to understand how Keystone Postbiotics' deliberately chosen active components contribute to maintaining a robust gut microbiome and a well-regulated immune response.
  • The preclinical data contributed to the decision by Verb Biotics to commence human clinical studies in January 2024 to evaluate the potential support of foundational gut microbiome health by Keystone Postbiotic™.
  • Keystone Postbiotic™ combines strains, grains, and botanicals to deliver functional redundancy to support foundational gut microbiome health.

DEXSORB® APPROVED TO TREAT PFAS IN MASSACHUSETTS

Retrieved on: 
Thursday, March 14, 2024
RCRA, Environmental protection, Cyclodextrin, Attention, PFNA, PFAS, PFOS, Environment, Bartlett, City, Cancer, PFOA, Groundwater, Carbon, MMCL, Drinking, NSF, EPA, Water, Immune system, Safety, AECOM, DWP, Perfluorohexanesulfonic acid, Drinking water, Cosmetics

In October 2020, MassDEP established the Massachusetts Maximum Contaminant Level (MMCL), a PFAS public drinking water standard, at 20 parts per trillion (ppt) for the sum of concentrations of six PFAS chemicals: PFOS, PFOA, PFHxS, PFNA, PFHpA, and PFDA.

Key Points: 
  • In October 2020, MassDEP established the Massachusetts Maximum Contaminant Level (MMCL), a PFAS public drinking water standard, at 20 parts per trillion (ppt) for the sum of concentrations of six PFAS chemicals: PFOS, PFOA, PFHxS, PFNA, PFHpA, and PFDA.
  • Made with renewable cyclodextrins, the media features 0.78 nanometer adsorbent cups with molecular selectivity for PFAS.
  • The media is certified to NSF/ANSI/CAN 61 standards, validating its safety for use to treat public drinking water.
  • The ability to regenerate DEXSORB and isolate PFAS waste in concentrated form makes it highly compatible with destruction technologies."

Biotech's Role in Addressing the Pancreatic Cancer Emergency

Retrieved on: 
Thursday, March 14, 2024
Ovarian cancer, Immunotherapy, Patient, History, Lutetium (177Lu) oxodotreotide, IND, Cancer, NVS, NUVB, NCI, Novartis, Science, Colorectal cancer, Risk, American Cancer Society, FOLFIRINOX, PDAC, Pancreatic Cancer Action Network, Safety, Immune system, Interim, University, Translational research, Survival rate, Disease, Clinical professor, Associate, Tumor microenvironment, Death, TSX, Pancreatic cancer, Sunnybrook Health Sciences Centre, ACRS, FDA, DCP, Diagnosis, Entrepreneurship, Environment, Physician, Triple-negative breast cancer, Mortality, News, PROC, DDC, Hereditary nonpolyposis colorectal cancer, Optimism, ONC, Pharmaceutical industry

VANCOUVER, BC, March 14, 2024 /PRNewswire/ -- USA News Group - Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working diligently to improve the chances of those who receive this dire diagnosis. Recently, in late 2023, researchers at the Mayo Clinic made a discovery that advances knowledge of how pancreatic cancer spreads and identified a new potential therapeutic target along the way. With the American Cancer Society projecting a record year for new cancer cases in 2024, and Europe facing a pancreatic cancer emergency, it's important to focus on the advances being made in the biotech sector that are giving hope to patients and their families. Among the developers making gains include Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Novartis AG (NYSE: NVS), ImmunityBio, Inc. (NASDAQ: IBRX), Aclaris Therapeutics, Inc. (NASDAQ: ACRS), and Nuvation Bio Inc. (NYSE: NUVB). 

Key Points: 
  • There is a point of optimism to build upon, as the Pancreatic Cancer Action Network (PanCAN) has stated the five-year survival rate for pancreatic cancer has increased to 13% .
  • "Combining pelareorep with mFOLFIRINOX represents an expansion of our existing pancreatic cancer program and maximizes the potential of pelareorep-based combination therapies to benefit pancreatic cancer patients."
  • It will focus on patients with pancreatic cancer, HER2-negative metastatic breast cancer, metastatic castration-resistant prostate cancer (mCRPC), and platinum-resistant ovarian cancer (PROC).
  • Nuvation is already undergoing dosing in the Phase 1 monotherapy study of NUV-868 in solid tumors in patients with pancreatic cancer, ovarian cancer, metastatic castration-resistant prostate cancer (mCRPC), triple-negative breast cancer and other solid tumors.